Sign in
4/A

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-004954

Chief Executive Officer bought 1,340 shares at $7.64 ($10,238)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-11-22 Purchase : show line 1 in the form +1,340 $7.64 $10,238 32,830 D
Open-market purchases · 1,340 sh · avg $7.64 · $10,238
Loading xslF345X03/doc4a.xml…